Second-generation immunotherapeutics in multiple sclerosis: can we discard their precursors?

Oliver Findling, Johann Sellner

Research output: Journal article (peer-reviewed)Review article

14 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Second-generation immunotherapeutics in multiple sclerosis: can we discard their precursors?'. Together they form a unique fingerprint.

Medicine and Dentistry

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science